Testing effectiveness (Phase 2)Study completedNCT02028442
What this trial is testing
Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients
Who this might be right for
Solid Tumours of Epithelial OriginMetastatic Colorectal CancerMetastatic Bladder Cancer
Akamis Bio 61